Skip to main content

Cardinal Health Value Stock - Dividend - Research Selection

Cardinal health

ISIN: US14149Y1082 , WKN: 880206

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Cardinal Health, Inc. operates as an integrated healthcare services and products company worldwide. The company\'s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers. This segment also operates nuclear pharmacies and manufacturing facilities that manufacture, prepare, and deliver radiopharmaceuticals, as well as operates direct-to-patient specialty pharmacies; offers logistics, marketing, and other services; and repackages generic pharmaceuticals and over-the-counter healthcare products. The company\'s Medical segment manufactures and sources medical, surgical, and laboratory products, including cardiovascular and endovascular products; wound care products; surgical drapes, gowns, and apparel; exam and surgical gloves; fluid suction and collection systems; and incontinence, enteral feeding, urology, operating room supply, electrode and needle, and syringe and sharps disposal product lines. It also distributes medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers, as well as to patients in the home; and assembles and sells sterile and non-sterile procedure kits. In addition, it offers supply chain services to healthcare providers; and post-acute care management, and transition services and software to hospitals, other healthcare providers, and payers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Here's Why You Should Retain BDX Stock in Your Portfolio Now

2026-04-16
BD benefits from innovation, strategic deals and strong Q1 results, but reimbursement risks and estimate cuts may temper near-term upside.

Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors

2026-04-15
In the latest trading session, Cardinal Health (CAH) closed at $211.83, marking a -1.45% move from the previous day.

Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

2026-04-15
MMSI rides strong cardiovascular demand, therapeutic growth and innovation push, but tariffs, China pressure and OEM weakness cloud its near-term outlook.

Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium

2026-04-15
AVNS stock jumps after agreeing to a $1.27B all-cash buyout by AIP at a 72% premium, offering shareholders immediate value and setting up a private-market shift.

Wall Street Bulls Look Optimistic About Cardinal (CAH): Should You Buy?

2026-04-15
Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Is This the Right Time to Add PAHC Stock to Your Portfolio?

2026-04-15
Phibro Animal Health rides on strong Animal Health and vaccine demand, but macro risks and generics pressure cloud its outlook despite standout stock gains.

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

2026-04-14
ECL stock gains on strong Q4 results and expanding high-tech water solutions and digital platforms. Ovivo deal and R&D push support growth amid macro headwinds.

Avantor Stock Up as New Lab Capabilities Improve Biopharma Support

2026-04-14
AVTR stock gains after expanding U.S. lab capabilities, boosting biopharma support, streamlining testing and strengthening supply chain efficiency.

Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings

2026-04-14
Today, Cardinal Health (NYSE: CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care. Advanced therapies are innovative gene-, cell- and tissue-based treatments that target the root cause of disease by repairing, replacing or regenerating damaged cells, offering long-term benefits for many conditions. As more therapies shift to outpatient and community-based settings,

Evercore ISI Trims Cardinal Health (CAH) Target While Maintaining Bullish Rating

2026-04-13
Cardinal Health, Inc. (NYSE:CAH) is included among the 15 Cash-Rich Dividend Stocks to Invest in Right Now. On April 8, Evercore ISI analyst Elizabeth Anderson lowered the price recommendation on Cardinal Health, Inc. (NYSE:CAH) to $240 from $260. It reiterated an Outperform rating on the shares. The firm made several adjustments as part of its […]